- Malaria Research
- Schisto Research
- Toxoplasma Research
- Tuberculosis Research
- General Open Research
- Getting Started
- Resources Needed
Can open-source R&D reinvigorate drug research - Nature
Communitygeneral open research
Bernard Munos, from Eli Lilly, wrote a very thorough article on open and collaborative research for neglected diseases and it was just published at Nature: Can open-source R&D reinvigorate drug research. What I particularly like about the article are the details he provides in describing how he thinks pharmaceutical companies can and should participate in the process.
Let's face it; we're in uncharted territory. We don't really KNOW how it's going to work. We're in the midst of a big evolving experimental process.
My vision for how it will work tends to be a bit more grass roots, less centralized group driving the process. Collaborative process tools like a Gene Wiki will enable dedicated experts to suggest work for less involved volunteers to contribute. People will collaborate with the people they trust and trust must be earned.
The nice thing is that I firmly believe that both the centralized group idea of Bernard's vision and my grass roots vision can co-exist peacefully and occasionally collaborate together. Again, it will be a matter of trust. Over time, the centralized group may win over the grass roots contributors and bring them into the fold. Again, it's all a matter of trust...